Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:50:27 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



Q:KZR - KEZAR LIFE SCIENCES INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
KZR - Q0.10.7179·0.8252.30.79+0.00240.3421.82161,4460.78  0.8044  0.77113.13  0.674619:15:58Apr 0815 min RT 2¢

Recent Trades - Last 10 of 1446
Time ETExPriceChangeVolume
19:15:58Q0.79990.01232
18:24:21Q0.79990.01232
18:23:44Q0.79980.01223
17:22:34Q0.7990.011415
17:10:48Q0.7990.011450
16:59:43Q0.79980.01226
16:58:40Q0.79990.012324
16:45:00Q0.7755-0.0121300
16:37:24Q0.79980.0122122
16:11:34Q0.80290.015340

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-08 16:01U:KZRNews ReleaseKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2024-03-14 16:01U:KZRNews ReleaseKezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
2024-03-08 16:05U:KZRNews ReleaseKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2024-02-28 16:01U:KZRNews ReleaseKezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
2024-02-26 18:30U:KZRNews ReleaseEverest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
2023-11-21 16:01U:KZRNews ReleaseKezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
2023-11-13 16:01U:KZRNews ReleaseKezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
2023-11-03 16:03U:KZRNews ReleaseKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2023-10-09 17:56U:KZRNews ReleaseKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2023-10-03 16:10U:KZRNews ReleaseKezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer
2023-09-20 18:30U:KZRNews ReleaseKezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia
2023-08-31 16:01U:KZRNews ReleaseKezar Life Sciences to Participate in Three Upcoming Investor Conferences
2023-08-10 16:01U:KZRNews ReleaseKezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
2023-08-04 16:03U:KZRNews ReleaseKezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2023-07-07 16:01U:KZRNews ReleaseKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2023-06-09 16:01U:KZRNews ReleaseKezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2023-05-31 07:00U:KZRNews ReleaseKezar Life Sciences to Participate in the Jefferies Healthcare Conference
2023-05-11 16:01U:KZRNews ReleaseKezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update